Pulse Biosciences, Inc.
PLSE
$21.25
$0.321.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.43M | -19.39M | -19.17M | -16.80M | -19.39M |
| Total Depreciation and Amortization | 259.00K | 256.00K | 273.00K | 283.00K | 287.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.12M | 5.62M | 5.19M | 5.68M | 7.72M |
| Change in Net Operating Assets | -3.70M | 473.00K | 899.00K | -2.69M | 2.23M |
| Cash from Operations | -14.76M | -13.04M | -12.81M | -13.52M | -9.14M |
| Capital Expenditure | -105.00K | -62.00K | -103.00K | -45.00K | -53.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -20.00K | -- | -- |
| Cash from Investing | -105.00K | -62.00K | -123.00K | -45.00K | -53.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 381.00K | 1.97M | 0.00 | 14.81M | 48.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -59.00K |
| Cash from Financing | 381.00K | 1.97M | 0.00 | 14.81M | 48.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.48M | -11.14M | -12.93M | 1.24M | 39.01M |